JPH09322781A - Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓポリヌクレオチドおよび配列 - Google Patents

Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓポリヌクレオチドおよび配列

Info

Publication number
JPH09322781A
JPH09322781A JP2016097A JP2016097A JPH09322781A JP H09322781 A JPH09322781 A JP H09322781A JP 2016097 A JP2016097 A JP 2016097A JP 2016097 A JP2016097 A JP 2016097A JP H09322781 A JPH09322781 A JP H09322781A
Authority
JP
Japan
Prior art keywords
sequence
staphylococcus aureus
seq
nucleotide sequence
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2016097A
Other languages
English (en)
Japanese (ja)
Other versions
JPH09322781A5 (https=
Inventor
Charles A Kunsch
エイ． クンシュ チャールズ
Gil H Choi
エイチ． チョイ ギル
Steven C Barash
シー． バラッシュ スティーブン
Patrick J Dillon
ジェイ． ディロン パトリック
Michael R Fannon
アール． ファノン マイケル
Craig A Rosen
エイ． ローゼン クレイグ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of JPH09322781A publication Critical patent/JPH09322781A/ja
Publication of JPH09322781A5 publication Critical patent/JPH09322781A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
JP2016097A 1996-01-05 1997-01-06 Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓポリヌクレオチドおよび配列 Withdrawn JPH09322781A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US986196P 1996-01-05 1996-01-05
US60/009,861 1996-01-05

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2003431638A Division JP2004135679A (ja) 1996-01-05 2003-12-25 Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓポリヌクレオチドおよび配列

Publications (2)

Publication Number Publication Date
JPH09322781A true JPH09322781A (ja) 1997-12-16
JPH09322781A5 JPH09322781A5 (https=) 2004-12-09

Family

ID=21740142

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016097A Withdrawn JPH09322781A (ja) 1996-01-05 1997-01-06 Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓポリヌクレオチドおよび配列
JP2003431638A Withdrawn JP2004135679A (ja) 1996-01-05 2003-12-25 Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓポリヌクレオチドおよび配列

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2003431638A Withdrawn JP2004135679A (ja) 1996-01-05 2003-12-25 Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓポリヌクレオチドおよび配列

Country Status (4)

Country Link
US (2) US6737248B2 (https=)
EP (1) EP0786519A3 (https=)
JP (2) JPH09322781A (https=)
CA (1) CA2194411A1 (https=)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001055397A1 (fr) * 2000-01-28 2001-08-02 Keiichi Hiramatsu NOUVEAUX POLYPEPTIDES VraS ET VraR
JP2002542807A (ja) * 1999-05-03 2002-12-17 ジェン−プローブ・インコーポレーテッド ブドウ球菌属の検出および定量用のポリヌクレオチドプローブ
JP2003506011A (ja) * 1999-04-15 2003-02-18 ザ リージェンツ オブ ザ ユニヴァーシティー オブ カリフォルニア ソーターゼ遺伝子の同定
JP2003520034A (ja) * 1999-12-23 2003-07-02 ヴィマックス リミテッド ビルレンス遺伝子、タンパク質、およびそれらの用途
JP2004531245A (ja) * 2001-01-30 2004-10-14 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム Ｎｃｃ２７０５−ビフィドバクテリウムのゲノム
JP2008501318A (ja) * 2004-04-29 2008-01-24 アブシンス・バイオロジクス・リミテッド ポリペプチド
JP2008291035A (ja) * 2001-01-26 2008-12-04 Intercell Ag 特定の病原体に対する抗原の同定、単離および製造方法
JP2010088447A (ja) * 2002-12-06 2010-04-22 Innogenetics Nv ハイブリダイゼーションアッセイを使用する真正細菌群の検出、同定および区別
JP2012191945A (ja) * 1998-05-01 2012-10-11 Novartis Vaccines & Diagnostics Inc 髄膜炎菌抗原および組成物
KR20230086123A (ko) * 2021-12-08 2023-06-15 대한민국(농촌진흥청장) 작물의 초형을 조절하는 OsHDSTART1 유전자 및 이의 용도

Families Citing this family (244)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696561B1 (en) * 1909-07-09 2004-02-24 Basf Aktiengesellschaft Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
US6251647B1 (en) * 1993-12-06 2001-06-26 The Rockefeller University Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof
US6025132A (en) * 1994-06-24 2000-02-15 Innogenetics N.V. Probes targeted to rRNA spacer regions, methods and kits for using said probes, for the detection of respiratory tract pathogens
US20020055101A1 (en) 1995-09-11 2002-05-09 Michel G. Bergeron Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US5994066A (en) * 1995-09-11 1999-11-30 Infectio Diagnostic, Inc. Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US6514746B1 (en) 1995-09-15 2003-02-04 Essential Therapeutics, Inc. Staphylococcus aureus histidine protein kinase essential genes
WO1999032657A1 (en) * 1997-12-23 1999-07-01 Microcide Pharmaceuticals, Inc. Staphylococcus aureus histidine protein kinase essential genes
US6037123A (en) * 1995-09-15 2000-03-14 Microcide Pharmaceuticals, Inc. Methods of screening for compounds active on Staphylococcus aureus target genes
US5962283A (en) 1995-12-07 1999-10-05 Diversa Corporation Transminases and amnotransferases
US6833253B2 (en) * 1996-01-05 2004-12-21 Human Genome Sciences, Inc. Staphylococcus aureus polynucleotides and polypeptides
US6403337B1 (en) * 1996-01-05 2002-06-11 Human Genome Sciences, Inc. Staphylococcus aureus genes and polypeptides
WO1997026344A1 (en) * 1996-01-19 1997-07-24 Smithkline Beecham Plc ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS
GB9601067D0 (en) * 1996-01-19 1996-03-20 Smithkline Beecham Plc Novel compounds
EP1275720A3 (en) * 1996-01-19 2003-04-16 Smithkline Beecham Plc Histidyl-trna synthetase of staphylococcus aureus
EP0785268A1 (en) * 1996-01-19 1997-07-23 Smithkline Beecham Plc Staphylococcus aureus methionyl-tRNA synthetase
JP2000506385A (ja) * 1996-02-20 2000-05-30 スミスクライン・ビーチャム・コーポレイション 新規ｅｒａ
US5882891A (en) * 1996-02-20 1999-03-16 Smithkline Beecham Corporation Ferrichrome transport ATP-binding protein
US6010881A (en) 1996-02-20 2000-01-04 Smithkline Beecham Corporation RibG
US5989864A (en) * 1996-10-29 1999-11-23 Smithkline Beecham Corporation DNA encoding spo-rel polypeptides
GB9605381D0 (en) * 1996-03-14 1996-05-15 Smithkline Beecham Plc Novel compounds
GB9608000D0 (en) * 1996-04-18 1996-06-19 Smithkline Beecham Plc Novel compounds
GB9607991D0 (en) * 1996-04-18 1996-06-19 Smithkline Beecham Plc Novel compounds
GB9607993D0 (en) * 1996-04-18 1996-06-19 Smithkline Beecham Plc Novel compounds
US6165989A (en) * 1996-05-14 2000-12-26 Smithkline Beecham Corporation Era of Streptococcus pneumoniae
WO1998006734A1 (en) 1996-08-16 1998-02-19 Smithkline Beecham Corporation Novel prokaryotic polynucleotides, polypeptides and their uses
US6995254B1 (en) 1996-08-28 2006-02-07 Affinium Pharmaceuticals, Inc. Polynucleotide encoding the enoyl-acyl carrier protein reductase of Staphylococcus aureus, FAB I
DE69735225T2 (de) * 1996-08-28 2006-11-02 Affinium Pharmaceuticals, Inc., Toronto Fab I Enoyl-ACP-Reduktase aus Staphylokokken
US6107071A (en) * 1996-09-24 2000-08-22 Smithkline Beecham Corporation Histidinol dehydrogenase
US6013505A (en) * 1996-10-08 2000-01-11 Smithkline Beecham Corporation Topoisomerase I
US6025156A (en) * 1996-10-15 2000-02-15 Smithkline Beecham Corporation Topoisomerase III
US6348584B1 (en) * 1996-10-17 2002-02-19 John Edward Hodgson Fibronectin binding protein compounds
US5942419A (en) * 1996-10-24 1999-08-24 Smithkline Beecham P.L.C. RsbW-1 encoding nucleic acids
US6020160A (en) * 1996-10-24 2000-02-01 Smithkline Beecham Corporation RsbV-1 polynucleotides of Staphylococcus aureus
US6310192B1 (en) 1996-10-24 2001-10-30 Smithkline Beecham Corporation SigB
US6004556A (en) * 1996-10-24 1999-12-21 Smithkline Beecham Corporation Staphylococcus aureus RSBU-1
US20030049636A1 (en) 1999-05-03 2003-03-13 Bergeron Michel G. Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
US20100267012A1 (en) 1997-11-04 2010-10-21 Bergeron Michel G Highly conserved genes and their use to generate probes and primers for detection of microorganisms
US5827689A (en) * 1996-11-13 1998-10-27 Smithkline Beecham Corporation FabD polynucleotides
EP1329510A3 (en) * 1996-11-13 2003-08-27 SmithKline Beecham Corporation Staphylococcus FabD
US5955304A (en) * 1997-01-02 1999-09-21 Smithkline Beecham Corporation DivIB
US6022706A (en) * 1997-04-09 2000-02-08 Smithkline Beecham Corporation Div1b
US6258934B1 (en) 1997-01-24 2001-07-10 Smithkline Beecham Corporation FabD
EP1015602A1 (en) * 1997-02-03 2000-07-05 Yale University Glutrna gln amidotransferase - a novel essential translational component
US6410263B1 (en) * 1997-02-07 2002-06-25 Smithkline Beecham Corporation Histidine kinase
US6150340A (en) * 1997-02-07 2000-11-21 Smithkline Beecham Corporation RNA-dependent amidotransferase from Staphylococcus aureus
EP0861895A3 (en) * 1997-02-21 2000-01-26 Smithkline Beecham Corporation aroE shikimate 5 dehydrogenase from Staphylococcus Aureus
US6210940B1 (en) 1997-04-18 2001-04-03 Smithkline Beecham Corporation Compounds
US6586578B1 (en) 1997-05-21 2003-07-01 Smithkline Beecham Corporation Defl
EP0881285A1 (en) * 1997-05-29 1998-12-02 Smithkline Beecham Corporation D-Alanine transferase
US6204019B1 (en) * 1997-06-04 2001-03-20 Smithkline Beecham Corporation Sec A2 from Streptococcus pneumoniae
US5891678A (en) * 1997-06-04 1999-04-06 Smithkline Beecham Corporation DNA encoding the SecA1 polypeptide of Staphylococcus aureus
US5866367A (en) * 1997-07-01 1999-02-02 Smithkline Beecham Corporation Gidb
EP0892055A3 (en) * 1997-07-01 2002-03-20 Smithkline Beecham Corporation GidB polypeptides from Staphylococcus aureus
CA2236435A1 (en) * 1997-07-01 1999-01-01 Smithkline Beecham Corporation Gida2
CA2236452A1 (en) * 1997-07-01 1999-01-01 Smithkline Beecham Corporation Gida1
US6455323B1 (en) 1997-07-03 2002-09-24 Pharmacia & Upjohn Company Anti-bacterial methods and materials
US6838255B1 (en) * 1997-07-03 2005-01-04 Smithkline Beecham Corporation MurC
EP0890644A3 (en) * 1997-07-10 1999-09-29 Smithkline Beecham Corporation MurA gene from Staphylococcus aureus encoding DP-N-Acetylglucosamine enolpyruvyl transferase
US5889171A (en) * 1997-07-18 1999-03-30 Smithkline Beecham Corporation TarF
DE19731292A1 (de) * 1997-07-21 1999-01-28 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Nucleinsäuremolekül, Kit und Verwendung
EP0916729A3 (en) * 1997-07-23 1999-08-04 Smithkline Beecham Corporation Novel reductase
EP0893500A3 (en) * 1997-07-23 2001-10-17 Smithkline Beecham Corporation BmrU gene from Staphylococcus aureus
US5891670A (en) * 1997-07-23 1999-04-06 Smithkline Beecham Corporation Tetracycline resistance protein
US5994096A (en) * 1997-07-25 1999-11-30 Smithkline Beecham Corporation Regulator
EP0896060A3 (en) * 1997-08-08 2000-07-19 Smithkline Beecham Corporation RpoA gene from Staphylococcus aureus
US6258578B1 (en) * 1997-08-11 2001-07-10 Smithkline Beecham Corporation His5
US6180387B1 (en) * 1997-08-11 2001-01-30 Smithkline Beecham Corporation Arginine deiminase
US6335433B1 (en) * 1997-08-11 2002-01-01 Smithkline Beecham Corporation nrdD
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
US6225098B1 (en) * 1997-08-25 2001-05-01 Smithkline Beecham Corporation UDP-N-acetylenolpyruvyglucosamine reductase
US6274361B1 (en) * 1997-08-26 2001-08-14 Smithkline Beecham Corporation pth
US6331410B1 (en) * 1997-08-29 2001-12-18 Smithkline Beecham Corp. Polynucleotides encoding a novel pyrR homolog
US6124119A (en) 1997-09-04 2000-09-26 Smithkline Beecham Corporation mecB
US6284515B1 (en) * 1997-09-03 2001-09-04 Smithkline Beecham Corporation Signal recognition particle polypeptides and polynucleotides
US6080729A (en) * 1998-03-17 2000-06-27 Smithkline Beecham Corporation Spo0J2 of Staphylococcus aureus
WO1999011753A1 (en) * 1997-09-04 1999-03-11 Smithkline Beecham Corporation SpoOJ2 OF STAPHYLOCOCCUS AUREUS
EP0905233A2 (en) * 1997-09-04 1999-03-31 Smithkline Beecham Corporation Staphylococcus aureus trigger factor
US6524813B1 (en) * 1997-09-04 2003-02-25 Smithkline Beecham Corporation Polynucleotide encoding spo0J1 of Staphylococcus aureus
US5888771A (en) * 1997-09-04 1999-03-30 Smithkline Beecham Corporation Integral membrane proteins from Streptoccus pneumoniae
EP0911405A3 (en) * 1997-09-18 2000-01-19 SmithKline Beecham p.l.c. Gapdh
US6013497A (en) * 1997-09-25 2000-01-11 Smithkline Beecham Corporation MurE
EP0905249A3 (en) * 1997-09-25 1999-08-04 Smithkline Beecham Corporation Alcohol dehydrogenase
EP0905247A3 (en) * 1997-09-25 1999-10-20 Smithkline Beecham Corporation MurF polynucleotides and polypeptides from Staphylococcus
US6287807B1 (en) * 1997-09-25 2001-09-11 Smithkline Beecham Corporation MurF
JP2001507945A (ja) * 1997-10-03 2001-06-19 スミスクライン・ビーチャム・コーポレイション スタフィロコッカス・アウレウスのリボソームリサイクリングファクター（ｆｒｒ）
WO1999018187A1 (en) * 1997-10-03 1999-04-15 Smithkline Beecham Corporation NOVEL clpL
US6251629B1 (en) * 1997-10-07 2001-06-26 Smithkline Beecham Corporation ABC transporter
EP0913474A3 (en) * 1997-10-28 1999-12-29 Smithkline Beecham Corporation Dbpa, a helicase from Staphylococcus aureus
US5989858A (en) * 1997-10-28 1999-11-23 Smithkline Beecham Corporation Dead-type ATP-dependent RNA helicase (DbpB) from Staphylococcus aureus
US6346393B1 (en) 1997-11-06 2002-02-12 Smithkline Beecham Corp. Polynucleotides encoding a ribonuclease s
US6548633B1 (en) 1998-12-22 2003-04-15 Genset, S.A. Complementary DNA's encoding proteins with signal peptides
US6682919B1 (en) * 1997-11-14 2004-01-27 Smithkline Beecham Corporation FabH
EP1034277B1 (en) * 1997-11-26 2012-06-27 Inhibitex, Inc. Extracellular matrix-binding proteins from Staphylococcus aureus
US6680195B1 (en) * 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
AU1726199A (en) 1997-12-31 1999-07-19 Chiron Corporation Metastatic cancer regulated gene
US7432365B1 (en) 1998-01-27 2008-10-07 O'donnell Michael E DNA molecules encoding beta clamp proteins of gram positive bacteria
WO1999037661A1 (en) 1998-01-27 1999-07-29 The Rockefeller University Dna replication proteins of gram positive bacteria and their use to screen for chemical inhibitors
AU764441B2 (en) 1998-02-09 2003-08-21 Genset S.A. cDNAs encoding secreted proteins
US6448037B1 (en) * 1998-02-20 2002-09-10 Smithkline Beecham Corporation PgsA
WO1999045123A1 (en) * 1998-03-02 1999-09-10 Abbott Laboratories Recombinant staphylococcus thioredoxin reductase, and inhibitors thereof useful as antimicrobial agents
US6767536B1 (en) * 1998-03-02 2004-07-27 Ramot At Tel Aviv University Ltd. Recombinant Staphylococcus thioredoxin reductase and inhibitors thereof useful as antimicrobial agents
US6083924A (en) * 1998-03-12 2000-07-04 Smithkline Beecham Corporation DnaB of staphylococcus aureus
US6287804B1 (en) * 1998-03-17 2001-09-11 Smithkline Beecham Corporation nrdG
US6555338B1 (en) * 1998-03-17 2003-04-29 Smithkline Beecham Corporation NrdF from Staphylococcus aureus
GB9806762D0 (en) * 1998-03-31 1998-05-27 Neutec Pharma Plc Treatment and diagnosis of staphylococcal infections
US6468743B1 (en) * 1998-05-18 2002-10-22 Conagra Grocery Products Company PCR techniques for detecting microbial contaminants in foodstuffs
US6117662A (en) * 1998-05-22 2000-09-12 Smithkline Beecham Corporation Respiratory nitrate reductase alpha subunit
WO1999065530A1 (en) * 1998-06-17 1999-12-23 Smithkline Beecham Corporation NrdD
WO1999067360A2 (en) * 1998-06-25 1999-12-29 Hemosol Inc. Media and methods for expansion of erythroid stem cells for the production of hemoglobin
JP2002519055A (ja) * 1998-07-02 2002-07-02 スミスクライン・ビーチャム・コーポレイション Ｆｔｓｚ多量体蛋白およびその使用
US6222014B1 (en) * 1998-08-10 2001-04-24 Smithkline Beecham Corporation NrdE of staphylococcus aureus
WO2000011184A1 (en) * 1998-08-25 2000-03-02 Schering Corporation Staphylococcus aureus polypeptides
US20020092987A1 (en) * 1998-09-05 2002-07-18 Taehee Cho Photo detect device using quantum dots and materialization method thereof
US6222026B1 (en) * 1998-09-08 2001-04-24 Smithkline Beecham Corporation Gcp
US6110723A (en) * 1998-11-12 2000-08-29 Smithkline Beecham Corporation Yfii pseudouridine synthase
US7101969B1 (en) 1998-12-03 2006-09-05 Targanta Therapeutics Compositions and methods involving an essential Staphylococcus aureus gene and its encoded protein
US6982153B1 (en) 1998-12-03 2006-01-03 Targanta Therapeutics, Inc. DNA sequences from staphylococcus aureus bacteriophage 77 that encode anti-microbial polypeptides
US6451556B1 (en) 1998-12-21 2002-09-17 Smithkline Beecham Corporation EF-Tu
US6448038B1 (en) * 1999-01-26 2002-09-10 Smithkline Beecham Corporation BirA from staphylococcus aureus
US6720139B1 (en) 1999-01-27 2004-04-13 Elitra Pharmaceuticals, Inc. Genes identified as required for proliferation in Escherichia coli
WO2000044765A1 (en) * 1999-01-27 2000-08-03 Smithkline Beecham Corporation Mvk
US6352840B1 (en) * 1999-02-01 2002-03-05 Smithkline Beecham Corporation pskG
WO2000050433A2 (en) * 1999-02-26 2000-08-31 Smithkline Beecham Corporation Staphylococcus aureus q13 polynucleotides, polypeptides and methods of use
WO2000056865A1 (en) * 1999-03-22 2000-09-28 Smithkline Beecham Corporation Histidine kinase
WO2000058331A1 (en) * 1999-03-26 2000-10-05 Smithkline Beecham Corporation Mvd
US6107058A (en) * 1999-03-26 2000-08-22 Smithkline Beecham Corporation ispA from Staphylococcus aureus
WO2000058441A1 (en) * 1999-03-26 2000-10-05 Smithkline Beecham Corporation STAPHYLOCOCCUS AUREUS ydjB RELATED TO THE LUXS AUTOINDUCER SYNTHESIS FAMILY
WO2000059918A1 (en) * 1999-04-07 2000-10-12 University Of Utah Research Foundation EUBACTERIAL tmRNA SEQUENCES AND USES THEREOF
WO2000061778A1 (en) * 1999-04-13 2000-10-19 Smithkline Beecham Corporation Staphylococcus aureus mvaa
US7101692B2 (en) 1999-04-15 2006-09-05 The Regents Of The University Of California Identification of sortase gene
JP2002542821A (ja) * 1999-04-30 2002-12-17 ハイブリジェニックス・ソシエテ・アノニム ツーハイブリッドシステムのための原核ｄｎａコレクション、ヘリコバクター・ピロリのタンパク質−タンパク質相互作用およびその用途
US6821770B1 (en) 1999-05-03 2004-11-23 Gen-Probe Incorporated Polynucleotide matrix-based method of identifying microorganisms
WO2000071568A1 (en) * 1999-05-04 2000-11-30 Smithkline Beecham Corporation Staphylococcal ica operon
AU5561599A (en) * 1999-05-05 2000-11-21 Sterrenbeld Biotechnologie North America, Inc. Dna promoter sequence for gene expression
EP1178820A4 (en) * 1999-05-06 2003-04-23 Smithkline Beecham Corp METHODS FOR MODULATING FABH ACTIVITY
WO2000068140A1 (en) * 1999-05-06 2000-11-16 Smithkline Beecham Corporation Signal transduction response regulator family of staphylococcus
US6194174B1 (en) * 1999-05-12 2001-02-27 Smithkline Beecham Corporation Histidine kinase, 636 HK, of staphylococcus aureus
US6489139B1 (en) 1999-06-24 2002-12-03 Smithkline Beecham Corporation FabZ from Staphylococcus aureus
KR100878336B1 (ko) * 1999-06-25 2009-01-14 백광산업 주식회사 탄소 대사 및 에너지 생산과 관련된 단백질을 코딩하는코리네박테리움 글루타미쿰 유전자
KR100878332B1 (ko) * 1999-06-25 2009-01-14 백광산업 주식회사 막 합성 및 막 운반 관련 단백질을 코딩하는코리네박테리움 글루타미쿰 유전자
AU781654B2 (en) * 1999-08-04 2005-06-02 Pharmacia & Upjohn Company Crystallization and structure determination of staphylococcus aureus thymidylate kinase
AU782516B2 (en) 1999-08-04 2005-08-04 Pharmacia & Upjohn Company Crystallization and structure determination of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (S. aureus MurB)
US6689595B1 (en) 1999-08-04 2004-02-10 Pharmacia & Upjohn Company Crystallization and structure determination of Staphylococcus aureus thymidylate kinase
WO2001010904A1 (en) * 1999-08-06 2001-02-15 Smithkline Beecham Corporation Map
US6294357B1 (en) * 1999-08-31 2001-09-25 Smithkline Beecham Corporation FabF from Staphylococcus aureus
EP1233974A4 (en) * 1999-09-01 2004-09-22 Human Genome Sciences Inc GENES AND POLYPEPTIDEDES 37 I STAPHYLOCOCCUS AUREUS / I
WO2001018249A1 (en) * 1999-09-10 2001-03-15 Smithkline Beecham Corporation Staphylococcus aureus kdtb polynucleotide and polypeptide
US6197546B1 (en) 1999-09-20 2001-03-06 Smithkline Beecham Corporation PcrA Helicase of Staphylococcus aureus
WO2001023403A1 (en) * 1999-09-27 2001-04-05 Smithkline Beecham Corporation ypga CLADE GENES
WO2001023418A1 (en) * 1999-09-28 2001-04-05 Smithkline Beecham Corporation YphC
EP1246935B1 (en) 1999-09-28 2013-08-14 Geneohm Sciences Canada Inc. Highly conserved genes and their use to generate probes and primers for detection of microorganisms
US6951729B1 (en) 1999-10-27 2005-10-04 Affinium Pharmaceuticals, Inc. High throughput screening method for biological agents affecting fatty acid biosynthesis
WO2001030806A1 (en) * 1999-10-28 2001-05-03 Smithkline Beecham Corporation Polynucleotides and polypeptides involved in biofilm biology and their uses
WO2001032022A1 (en) * 1999-11-04 2001-05-10 Smithkline Beecham Corporation YtgP
US6589738B1 (en) 1999-11-09 2003-07-08 Elitra Pharmaceuticals, Inc. Genes essential for microbial proliferation and antisense thereto
WO2001038345A1 (en) * 1999-11-24 2001-05-31 Smithkline Beecham Corporation Regulatable fabh constructs
RU2240327C2 (ru) * 1999-12-23 2004-11-20 Вмакс Лимитед Ген и белок вирулентности и их использование
US6316211B1 (en) 2000-01-26 2001-11-13 Smithkline Beecham Corporation ThdF
JP2005229801A (ja) * 2000-01-28 2005-09-02 Keiichi Hiramatsu 新規ポリペプチドＨｍｒＡ及びＨｍｒＢ
WO2001055443A1 (en) * 2000-01-31 2001-08-02 Pharmacia & Upjohn Company Crystallization and structure determination of staphylococcus aureus nad synthetase
EP1257561A4 (en) * 2000-02-24 2004-09-29 Anadys Pharmaceuticals Inc STAPHYLOKKOKE GTPASE OBG CLEOTIDE SEQUENCE ENCODING STAPHYLOKKOKES GTP BINDING PROTEIN
WO2001064855A1 (en) * 2000-03-01 2001-09-07 Smithkline Beecham Corporation Clpp
WO2001077365A2 (en) * 2000-04-06 2001-10-18 Pharmacia & Upjohn Company Antimicrobial methods and materials
WO2001088186A2 (en) * 2000-05-19 2001-11-22 Institut Pasteur Methods for detecting and identifying a gram positive bacteria in a sample
GB0014907D0 (en) 2000-06-20 2000-08-09 Univ Sheffield Antigenic polypeptides
US6864080B2 (en) 2000-06-30 2005-03-08 Pharmacia & Upjohn Company Crystallization and structure of Staphylococcus aureus peptide deformylase
WO2002006491A1 (fr) * 2000-07-18 2002-01-24 Center For Advanced Science And Technology Incubation, Ltd. Isopentenyl pyrophosphate isomerase
EP1399562A2 (en) * 2000-07-19 2004-03-24 PHARMACIA & UPJOHN COMPANY Complete nucleotide sequence of staphylococcus aureus ribosomal protein gene, s20 and methods for the identification of antibacterial substances
EA013564B1 (ru) * 2000-08-03 2010-06-30 Терапеутик Хьюман Поликлоналз Инк. Гуманизированный иммуноглобулин и содержащая его фармацевтическая композиция
SE0003573D0 (sv) * 2000-10-04 2000-10-04 Bengt Guss Method and means for producing novel von Willebrand factor binding proteins and their use in biotechnology
US8168773B2 (en) 2000-10-06 2012-05-01 Novozymes, Inc. Methods for monitoring multiple gene expression
US7048926B2 (en) 2000-10-06 2006-05-23 Affinium Pharmaceuticals, Inc. Methods of agonizing and antagonizing FabK
CA2433386C (en) 2000-12-19 2006-11-21 Targanta Therapeutics Inc. Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r9
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
CA2348042A1 (en) 2001-06-04 2002-12-04 Ann Huletsky Sequences for detection and identification of methicillin-resistant staphylococcus aureus
MXPA03011701A (es) * 2001-06-15 2004-12-06 Nhibitex Inc Anticuerpos monoclonales y policlonales de reaccion que reconocen las proteinas de superficie a partir de estafilococos coagulasa-negativos y staphylococcus aureus.
WO2003025004A2 (en) * 2001-09-18 2003-03-27 Affinium Pharmaceuticals, Inc. Purified bacterial polypeptides involved in nucleic acid processing
US20050214773A1 (en) * 2001-09-21 2005-09-29 Affinium Pharmaceuticals, Inc. Novel purified polypeptides from bacteria
WO2003025005A2 (en) * 2001-09-21 2003-03-27 Affinium Pharmaceuticals, Inc. Purified bacterial polypeptides involved in protein processing
FR2831187A1 (fr) * 2001-10-22 2003-04-25 Univ Aix Marseille Ii Methode de determination de l'activite bacteriostatique ou bactericide des agents antibiotiques par pcr quantitative
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
CA2473883A1 (en) * 2001-11-29 2003-06-12 Wyeth Holdings Corporation Alloiococcus otitidis open reading frames (orfs) encoding polypeptide antigens, immunogenic compositions and uses thereof
AU2003202378A1 (en) * 2002-02-04 2003-09-02 Affinium Pharmaceuticals, Inc. Novel purified polypeptides from staphylococcus aureus
US6946267B2 (en) * 2002-03-13 2005-09-20 Dr. Chip Biotechnology Inc. Method for detecting Staphylococcus aureus
WO2003084986A2 (en) * 2002-04-04 2003-10-16 Affinium Pharmaceuticals, Inc. Novel purified polypeptides involved in cellular metabolism
AU2003257470A1 (en) * 2002-07-18 2004-02-09 Henkel Kommanditgesellschaft Auf Aktien Detection of microorganisms
AU2003250080A1 (en) * 2002-07-18 2004-02-09 Vermicon Ag Oligonucleotides for detecting micro-organisms
JPWO2004020635A1 (ja) * 2002-08-28 2005-12-15 株式会社テクノネットワーク四国 バクテリオファージおよび細菌感染症治療剤
ES2360399T3 (es) * 2003-07-08 2011-06-03 Umc Utrecht Holding B.V. Uso terapéutico de lpi, un inhibidor de la vía de las lectinas de origen estafilocócico, en enfermedades inflamatorias.
FR2857375B1 (fr) * 2003-07-10 2007-11-09 Biomerieux Sa Procede de detection et/ou d'identification de bacteries de genre staphylococcus
CA2532024A1 (en) 2003-07-11 2005-01-20 Affinium Pharmaceuticals, Inc. Novel purified polypeptides from staphylococcus aureus
US7429464B2 (en) 2003-12-09 2008-09-30 Biomerieux, Inc. Methods for detecting bacterial pathogens
DE602004019564D1 (de) 2003-12-09 2009-04-02 Bio Merieux Inc Verfahren zum nachweis bakterieller krankheitserreger
EP1692511B1 (en) 2003-12-09 2012-09-19 bioMerieux, Inc. Method for recovering microorganisms from a sample
US20070134263A1 (en) 2004-02-18 2007-06-14 Anderson Annaliesa S Polypeptides for inducing a protective immune response against staphyloococcus aureus
US20070264278A1 (en) * 2004-09-17 2007-11-15 Anderson Annaliesa S Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus
US20080095792A1 (en) * 2004-09-17 2008-04-24 Anderson Annaliesa S Polypeptides For Inducing A Protective Immune Response Against Staphylococcus Aureus
NZ553776A (en) 2004-09-22 2010-05-28 Glaxosmithkline Biolog Sa Immunogenic composition comprising staphylococcal PNAG and Type 5 and/or 8 Capsular polysaccharide or oligosaccharide.
AU2006206577B2 (en) 2005-01-21 2012-03-08 Merck Sharp & Dohme Corp. Polypeptides for inducing a protective immune response against Staphylococcus aureus
ATE490342T1 (de) * 2005-02-07 2010-12-15 Gen Probe Inc Zusammensetzungen und verfahren zum nachweis von streptokokken der gruppe b
WO2006111028A1 (en) * 2005-04-21 2006-10-26 Uti Limited Partnership Pcr for mrsa sccmec typing
US11834720B2 (en) * 2005-10-11 2023-12-05 Geneohm Sciences, Inc. Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ types xi to xx
EP1996231A4 (en) * 2006-02-22 2010-09-15 Texas A & M Univ Sys ANTIBODIES WITH STRONG EXPRESSED PUTATIVE ANTIGEN DETECTION OF CA-MRSA AND METHOD OF USE
EP2476433A1 (en) 2006-03-30 2012-07-18 GlaxoSmithKline Biologicals S.A. Immunogenic composition
WO2007123386A1 (es) * 2006-04-24 2007-11-01 Sigma Alimentos, S.A. De C.V. Método para la detección y cuantificación múltiple y simultánea de patógenos mediante la reacción en cadena de la polimerasa en tiempo real
CA2651946A1 (en) * 2006-05-12 2007-11-22 Gen-Probe Incorporated Compositions and methods to detect enterococci nucleic acid
CA2654460A1 (en) * 2006-05-23 2007-11-29 Tufts University Methods and compositions for the treatment and prevention of staphylococcus aureus infections through interference with opuc operon interaction with trap
PE20081216A1 (es) 2006-09-01 2008-09-04 Therapeutic Human Polyclonals Inc Expresion mejorada de la inmunoglobulina humana o humanizada en animales transgenicos no humanos
US20100099088A1 (en) * 2006-10-13 2010-04-22 Universite Laval Reliable detection of vancomycin-intermediate staphylococcus aureus
CN101627133A (zh) * 2007-01-08 2010-01-13 株式会社美迪基尼斯 用于金黄色葡萄球菌检测的dna芯片
CA2684570A1 (en) 2007-04-19 2008-10-30 Molecular Detection Inc. Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
JP5658564B2 (ja) * 2007-08-31 2015-01-28 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
WO2009082398A1 (en) * 2007-12-21 2009-07-02 University Of Notre Dame Du Lac Antibacterial compounds and methods of using same
RU2010144789A (ru) * 2008-04-01 2012-05-10 Метаметрикс Клиникал Лэборетери (Us) Процесс и способ мониторинга желудочно-кишечной микрофлоры
WO2010014304A1 (en) * 2008-07-29 2010-02-04 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
US8318180B2 (en) * 2008-09-30 2012-11-27 University Of Maryland, Baltimore Protective vaccine against Staphylococcus aureus biofilms comprising cell wall-associated immunogens
US9175353B2 (en) 2008-11-14 2015-11-03 Gen-Probe Incorporated Compositions, kits and methods for detection of campylobacter nucleic acid
EP2376111A4 (en) 2008-11-26 2013-01-09 Merck Sharp & Dohme POLYPEPTIDES FOR INDUCING A PROTECTIVE IMMUNE RESPONSE AGAINST STAPHYLOCOCCUS AUREUS
MX2011005578A (es) 2008-11-26 2011-06-30 Merck Sharp & Dohme Polipeptidos para inducir una respuesta inmune protectora contra staphylococcus aureus.
HUE026855T2 (en) 2009-04-03 2016-07-28 Univ Chicago Compositions and methods related to protein a (spa) variants
SA110310528B1 (ar) 2009-06-22 2014-07-02 Wyeth Llc التركيبات المولدة للمناعة لأنتيجينات ستافيلوكوكس أوريس
EP2555794A4 (en) 2010-04-05 2014-01-15 Univ Chicago COMPOSITIONS AND METHODS RELATING TO PROTEIN A (SPA) ANTIBODIES AS IMMUNE REACTION AMPLIFIERS
CA2803298C (en) 2010-07-02 2020-07-14 The University Of Chicago Compositions and methods related to protein a (spa) variants
WO2012021229A1 (en) 2010-07-13 2012-02-16 Merck Sharp & Dohme Corp. Staphylococcus aureus surface protein sa1789 and protective vaccine based thereon
EP2614074A1 (en) 2010-09-09 2013-07-17 The University of Chicago Methods and compositions involving protective staphylococcal antigens
EP2638058B1 (en) 2010-11-12 2017-01-11 Merck Sharp & Dohme Corp. Enolase peptide conjugate vaccines against staphylococcus aureus
US9085631B2 (en) * 2011-04-08 2015-07-21 Nov Vac APS Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
JP6670106B2 (ja) 2012-04-26 2020-03-18 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ ブドウ球菌コアグラーゼ抗原およびその使用方法
US9376487B2 (en) 2012-07-10 2016-06-28 Merck Sharp & Dohme Corp. Protective vaccine based on Staphylococcus aureus SA2493 protein
EP2968603B1 (en) 2013-03-15 2020-06-24 Techulon Inc. Antisense molecules for treatment of staphylococcus aureus infection
AU2015319834A1 (en) 2014-09-25 2017-04-20 University Of Notre Dame Du Lac Non-beta lactam antibiotics
JP7523776B2 (ja) * 2016-01-21 2024-07-29 ティー２ バイオシステムズ，インコーポレーテッド 細菌を迅速に検出するｎｍｒ法及びシステム
WO2018049404A1 (en) 2016-09-12 2018-03-15 University Of Notre Dame Du Lac Compounds for the treatment of clostridium difficile infection
US11572591B2 (en) 2017-04-26 2023-02-07 The Translational Genomics Research Institute Methods and assays for subtyping Staphylococcus aureus clonal complex 8 strains
WO2018200887A1 (en) * 2017-04-26 2018-11-01 The Translational Genomics Research Institute Methods and assays for subtyping staphylococcus aureus clonal complex 8 strains
AU2018379996A1 (en) 2017-12-05 2020-06-25 BioPlx, Inc. Methods and compositions to prevent microbial infection
US12514914B2 (en) 2019-05-14 2026-01-06 The University Of Chicago Methods and compositions comprising Staphylococcus protein a (SpA) variants
US20220310197A1 (en) * 2019-06-06 2022-09-29 Tata Consultancy Services Limited System and method for combating pseudomonas aeruginosa and staphylococcus aureus infections
US12442010B2 (en) * 2019-06-19 2025-10-14 Pioneer Hi-Bred International, Inc. Pod shatter tolerance in Brassica plants
CN114929750B (zh) 2019-09-13 2024-11-22 芝加哥大学 用于治疗葡萄球菌感染的方法和组合物
CN110982757B (zh) * 2019-12-30 2021-04-06 浙江工业大学 阴沟肠杆菌zjph1903及应用
CN116024371B (zh) * 2022-11-28 2024-12-13 迪飞医学科技(南京)有限公司 一种多重qPCR检测病原菌的引物探针组、试剂盒和检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187775A (en) 1990-03-15 1993-02-16 Dnastar, Inc. Computer representation of nucleotide and protein sequences
US5292874A (en) 1991-09-04 1994-03-08 Gen-Probe Incorporated Nucleic acid probes to Staphylococcus aureus
US6037123A (en) * 1995-09-15 2000-03-14 Microcide Pharmaceuticals, Inc. Methods of screening for compounds active on Staphylococcus aureus target genes

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016222709A (ja) * 1998-05-01 2016-12-28 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 髄膜炎菌抗原および組成物
JP2013255503A (ja) * 1998-05-01 2013-12-26 Novartis Vaccines & Diagnostics Inc 髄膜炎菌抗原および組成物
JP2013252140A (ja) * 1998-05-01 2013-12-19 Novartis Vaccines & Diagnostics Inc 髄膜炎菌抗原および組成物
JP2012191945A (ja) * 1998-05-01 2012-10-11 Novartis Vaccines & Diagnostics Inc 髄膜炎菌抗原および組成物
JP2003506011A (ja) * 1999-04-15 2003-02-18 ザ リージェンツ オブ ザ ユニヴァーシティー オブ カリフォルニア ソーターゼ遺伝子の同定
JP4913282B2 (ja) * 1999-05-03 2012-04-11 ジェン−プローブ・インコーポレーテッド ブドウ球菌属の検出および定量用のポリヌクレオチドプローブ
JP2002542807A (ja) * 1999-05-03 2002-12-17 ジェン−プローブ・インコーポレーテッド ブドウ球菌属の検出および定量用のポリヌクレオチドプローブ
JP2003520034A (ja) * 1999-12-23 2003-07-02 ヴィマックス リミテッド ビルレンス遺伝子、タンパク質、およびそれらの用途
JPWO2001055397A1 (ja) * 2000-01-28 2004-01-08 平松　啓一 新規ポリペプチドＶｒａＳ及びＶｒａＲ
WO2001055397A1 (fr) * 2000-01-28 2001-08-02 Keiichi Hiramatsu NOUVEAUX POLYPEPTIDES VraS ET VraR
JP2008291035A (ja) * 2001-01-26 2008-12-04 Intercell Ag 特定の病原体に対する抗原の同定、単離および製造方法
JP2004531245A (ja) * 2001-01-30 2004-10-14 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム Ｎｃｃ２７０５−ビフィドバクテリウムのゲノム
JP2010088447A (ja) * 2002-12-06 2010-04-22 Innogenetics Nv ハイブリダイゼーションアッセイを使用する真正細菌群の検出、同定および区別
JP2008501318A (ja) * 2004-04-29 2008-01-24 アブシンス・バイオロジクス・リミテッド ポリペプチド
KR20230086123A (ko) * 2021-12-08 2023-06-15 대한민국(농촌진흥청장) 작물의 초형을 조절하는 OsHDSTART1 유전자 및 이의 용도

Also Published As

Publication number Publication date
CA2194411A1 (en) 1997-07-06
US20030054436A1 (en) 2003-03-20
US6737248B2 (en) 2004-05-18
JP2004135679A (ja) 2004-05-13
US20070020746A1 (en) 2007-01-25
EP0786519A2 (en) 1997-07-30
EP0786519A3 (en) 1998-10-14

Similar Documents

Publication Publication Date Title
AU2020204194B2 (en) Optimal soybean loci
KR101914245B1 (ko) 박테리아성 균주를 함유한 조성물
AU2016278067B2 (en) Compositions comprising bacterial strains
AU745787B2 (en) Enterococcus faecalis polynucleotides and polypeptides
CN108138122B (zh) 免疫调控
JPH09322781A (ja) Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓポリヌクレオチドおよび配列
KR20180081509A (ko) 박테리아 균주를 포함하는 조성물
KR102531695B1 (ko) 프로바이오틱으로서 사용하기 위한 락토바실러스, 및 프로바이오틱을 비롯한 제제에 대한 면역 반응을 평가하기 위해 사용되는 혈액 세포 집단
AU2018232902A1 (en) Complete genome sequence of the methanogen methanobrevibacter ruminantium
HK1255426A1 (zh) 包含细菌菌株的组合物
KR102411381B1 (ko) 서팩틴 및 효소 생산능이 우수한 바실러스 서브틸리스 균주 및 이의 용도
KR102191537B1 (ko) 포유류에서 골 소실을 예방하는 젖산균의 선별 및 이의 용도
AU2015327511B2 (en) Biomarkers for rheumatoid arthritis and usage thereof
RU2673715C2 (ru) Вакцина против haemophilus parasuis серологического типа 4
KR20200019882A (ko) 세균 균주를 포함하는 조성물
AU2022256122A1 (en) Novel Proteins From Anaerobic Fungi And Uses Thereof
AU2016295176A1 (en) Genetic testing for predicting resistance of gram-negative proteus against antimicrobial agents
CN112243377A (zh) 用于治疗和预防细菌相关的癌症的噬菌体
KR20200038970A (ko) 박테리아 균주를 포함하는 조성물
KR20240021274A (ko) 반코마이신 내성 장구균에 대한 박테리오파지
KR20240000456A (ko) Covid-19의 치료를 위한 프로바이오틱 조성물
AU2018256922B2 (en) Targeted gene disruption methods and immunogenic compositions
KR20220135669A (ko) 서팩틴을 생산하는 신규한 바실러스 서브틸리스 균주 및 이의 용도
KR20190059562A (ko) γPGA 활성을 가지는 신규 고초균 및 이의 용도
KR20190057791A (ko) 단백질 분해활성을 가지는 신규한 고초균 및 이의 용도

Legal Events

Date Code Title Description
A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20050323